The ERA Endometrial Receptivity Analysis is a state-of-the-art diagnostic method that has been developed and patented in 2009 by IGENOMIX after over 10 years of research. This technique helps evaluate the woman’s endometrial receptivity from a molecular perspective.

An endometrium is receptive when it is ready for the embryo implantation. This occurs around days 19-21 in each menstrual cycle of a fertile woman. This period of receptivity is what we call the window of implantation.

The lack of synchronisation between the embryo ready to be implanted and endometrial receptivity is one of the causes of recurring implantation failure. This is why it is imperative to assess the endometrium in order to determine the optimal day for embryo transfer.

The ERA test requires an endometrial biopsy that should be carried out on day LH+7 (natural cycle) or day P+5 (HRT cycle). This biopsy is quickly and easily taken by a gynecologist in their consultation room. After being sent away, the sequencing expression of 236 genes involved in the endometrial receptivity is analyzed. An in-house designed computational predictor analyses the data obtained, classifying the endometrium as Receptive or Non-Receptive.